Kulicke Soffa Director Sold: What It Means for Investors
When a kulicke soffa director sold 20,000 shares for about $2 million, it prompts questions about insider intent and ...
Zero Based Budgeting For Starting A Business
Zero Based Budgeting for startups helps allocate scarce resources efficiently. Learn how to map expenses to revenue goals and sustain early growth.
21,083 articles
What Sunrun Co-Founder's Sale Means for Investors
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
Here's Much Better NASDAQ-100 Stock to Buy Now
As chatter swirls about SpaceX joining the NASDAQ-100, savvy investors are asking for a safer, higher-conviction pick...
Oracle Just Fresh 52-Week Lows: Is AI Capex Panic Overshooting?
Oracle just fresh 52-week lows as a credit downgrade highlights the tension between expensive AI infrastructure and c...
Kyndryl Stock Popped Today: A Closer Look for Investors
When KD shares surged mid-morning, traders asked if the move reflected real earnings momentum or relief from a scare....
Look! Sky! It’s Amazon’s Flywheel in Action Today
Amazon’s drone ambitions are moving from pilot programs to a full-fledged logistics flywheel. Prime Air aims for hund...
InMode (INMD) 2026 Earnings: Strategy, Outlook & Risks
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Why Brazil Fund Opened Million in MELI Despite Steep Stock Drop
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
Anterix Stock 140%. Here's Why One Investor Spent $15.8M
Anterix stock surged 140% as a major investor disclosed a multi-million dollar buy. This article breaks down the driv...
Axcelis Corporate Controller Sells: Is ACLS Stock Worth It?
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Oracle Stock Down More Than From Its High: A Bargain?
Oracle's shares have fallen steeply as AI hype cooled. This article breaks down whether the stock is a value opportun...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status